408 related articles for article (PubMed ID: 37571809)
1. Sporozoite immunization: innovative translational science to support the fight against malaria.
Richie TL; Church LWP; Murshedkar T; Billingsley PF; James ER; Chen MC; Abebe Y; Natasha Kc ; Chakravarty S; Dolberg D; Healy SA; Diawara H; Sissoko MS; Sagara I; Cook DM; Epstein JE; Mordmüller B; Kapulu M; Kreidenweiss A; Franke-Fayard B; Agnandji ST; López Mikue MA; McCall MBB; Steinhardt L; Oneko M; Olotu A; Vaughan AM; Kublin JG; Murphy SC; Jongo S; Tanner M; Sirima SB; Laurens MB; Daubenberger C; Silva JC; Lyke KE; Janse CJ; Roestenberg M; Sauerwein RW; Abdulla S; Dicko A; Kappe SHI; Sim BKL; Duffy PE; Kremsner PG; Hoffman SL
Expert Rev Vaccines; 2023; 22(1):964-1007. PubMed ID: 37571809
[TBL] [Abstract][Full Text] [Related]
2. Protective efficacy and safety of radiation-attenuated and chemo-attenuated Plasmodium Falciparum sporozoite vaccines against controlled and natural malaria infection: a systematic review and meta-analysis of randomized controlled trials.
Abuelazm MT; Elzeftawy MA; Kamal MA; Badr H; Gamal M; Aboulgheit M; Abdelazeem B; Abd-Elsalam S; Abouzid M
Infection; 2024 Jun; 52(3):707-722. PubMed ID: 38319556
[TBL] [Abstract][Full Text] [Related]
3. A replication competent Plasmodium falciparum parasite completely attenuated by dual gene deletion.
Goswami D; Patel H; Betz W; Armstrong J; Camargo N; Patil A; Chakravarty S; Murphy SC; Sim BKL; Vaughan AM; Hoffman SL; Kappe SH
EMBO Mol Med; 2024 Apr; 16(4):723-754. PubMed ID: 38514791
[TBL] [Abstract][Full Text] [Related]
4. Progress with Plasmodium falciparum sporozoite (PfSPZ)-based malaria vaccines.
Richie TL; Billingsley PF; Sim BK; James ER; Chakravarty S; Epstein JE; Lyke KE; Mordmüller B; Alonso P; Duffy PE; Doumbo OK; Sauerwein RW; Tanner M; Abdulla S; Kremsner PG; Seder RA; Hoffman SL
Vaccine; 2015 Dec; 33(52):7452-61. PubMed ID: 26469720
[TBL] [Abstract][Full Text] [Related]
5. Protection against
Epstein JE; Paolino KM; Richie TL; Sedegah M; Singer A; Ruben AJ; Chakravarty S; Stafford A; Ruck RC; Eappen AG; Li T; Billingsley PF; Manoj A; Silva JC; Moser K; Nielsen R; Tosh D; Cicatelli S; Ganeshan H; Case J; Padilla D; Davidson S; Garver L; Saverino E; Murshedkar T; Gunasekera A; Twomey PS; Reyes S; Moon JE; James ER; Kc N; Li M; Abot E; Belmonte A; Hauns K; Belmonte M; Huang J; Vasquez C; Remich S; Carrington M; Abebe Y; Tillman A; Hickey B; Regules J; Villasante E; Sim BKL; Hoffman SL
JCI Insight; 2017 Jan; 2(1):e89154. PubMed ID: 28097230
[No Abstract] [Full Text] [Related]
6. Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection.
Lyke KE; Ishizuka AS; Berry AA; Chakravarty S; DeZure A; Enama ME; James ER; Billingsley PF; Gunasekera A; Manoj A; Li M; Ruben AJ; Li T; Eappen AG; Stafford RE; Kc N; Murshedkar T; Mendoza FH; Gordon IJ; Zephir KL; Holman LA; Plummer SH; Hendel CS; Novik L; Costner PJ; Saunders JG; Berkowitz NM; Flynn BJ; Nason MC; Garver LS; Laurens MB; Plowe CV; Richie TL; Graham BS; Roederer M; Sim BK; Ledgerwood JE; Hoffman SL; Seder RA
Proc Natl Acad Sci U S A; 2017 Mar; 114(10):2711-2716. PubMed ID: 28223498
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of a three-dose regimen of Plasmodium falciparum sporozoite vaccine in adults during an intense malaria transmission season in Mali: a randomised, controlled phase 1 trial.
Sissoko MS; Healy SA; Katile A; Zaidi I; Hu Z; Kamate B; Samake Y; Sissoko K; Mwakingwe-Omari A; Lane J; Imeru A; Mohan R; Thera I; Guindo CO; Dolo A; Niare K; Koïta F; Niangaly A; Rausch KM; Zeguime A; Guindo MA; Bah A; Abebe Y; James ER; Manoj A; Murshedkar T; Kc N; Sim BKL; Billingsley PF; Richie TL; Hoffman SL; Doumbo O; Duffy PE
Lancet Infect Dis; 2022 Mar; 22(3):377-389. PubMed ID: 34801112
[TBL] [Abstract][Full Text] [Related]
8. A double-blind, placebo-controlled phase 1/2a trial of the genetically attenuated malaria vaccine PfSPZ-GA1.
Roestenberg M; Walk J; van der Boor SC; Langenberg MCC; Hoogerwerf MA; Janse JJ; Manurung M; Yap XZ; García AF; Koopman JPR; Meij P; Wessels E; Teelen K; van Waardenburg YM; van de Vegte-Bolmer M; van Gemert GJ; Visser LG; van der Ven AJAM; de Mast Q; Natasha KC; Abebe Y; Murshedkar T; Billingsley PF; Richie TL; Sim BKL; Janse CJ; Hoffman SL; Khan SM; Sauerwein RW
Sci Transl Med; 2020 May; 12(544):. PubMed ID: 32434847
[TBL] [Abstract][Full Text] [Related]
9. Safety, Immunogenicity, and Protective Efficacy against Controlled Human Malaria Infection of
Jongo SA; Shekalaghe SA; Church LWP; Ruben AJ; Schindler T; Zenklusen I; Rutishauser T; Rothen J; Tumbo A; Mkindi C; Mpina M; Mtoro AT; Ishizuka AS; Kassim KR; Milando FA; Qassim M; Juma OA; Mwakasungula S; Simon B; James ER; Abebe Y; Kc N; Chakravarty S; Saverino E; Bakari BM; Billingsley PF; Seder RA; Daubenberger C; Sim BKL; Richie TL; Tanner M; Abdulla S; Hoffman SL
Am J Trop Med Hyg; 2018 Aug; 99(2):338-349. PubMed ID: 29943719
[TBL] [Abstract][Full Text] [Related]
10. Sterile protection against human malaria by chemoattenuated PfSPZ vaccine.
Mordmüller B; Surat G; Lagler H; Chakravarty S; Ishizuka AS; Lalremruata A; Gmeiner M; Campo JJ; Esen M; Ruben AJ; Held J; Calle CL; Mengue JB; Gebru T; Ibáñez J; Sulyok M; James ER; Billingsley PF; Natasha KC; Manoj A; Murshedkar T; Gunasekera A; Eappen AG; Li T; Stafford RE; Li M; Felgner PL; Seder RA; Richie TL; Sim BK; Hoffman SL; Kremsner PG
Nature; 2017 Feb; 542(7642):445-449. PubMed ID: 28199305
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity and Protective Efficacy of Radiation-Attenuated and Chemo-Attenuated PfSPZ Vaccines in Equatoguinean Adults.
Jongo SA; Urbano V; Church LWP; Olotu A; Manock SR; Schindler T; Mtoro A; Kc N; Hamad A; Nyakarungu E; Mpina M; Deal A; Bijeri JR; Ondo Mangue ME; Ntutumu Pasialo BE; Nguema GN; Owono SN; Rivas MR; Chemba M; Kassim KR; James ER; Stabler TC; Abebe Y; Saverino E; Sax J; Hosch S; Tumbo AM; Gondwe L; Segura JL; Falla CC; Phiri WP; Hergott DEB; García GA; Schwabe C; Maas CD; Murshedkar T; Billingsley PF; Tanner M; Ayekaba MO; Sim BKL; Daubenberger C; Richie TL; Abdulla S; Hoffman SL
Am J Trop Med Hyg; 2021 Jan; 104(1):283-293. PubMed ID: 33205741
[No Abstract] [Full Text] [Related]
12. The whole parasite, pre-erythrocytic stage approach to malaria vaccine development: a review.
Epstein JE; Richie TL
Curr Opin Infect Dis; 2013 Oct; 26(5):420-8. PubMed ID: 23982233
[TBL] [Abstract][Full Text] [Related]
13. Two chemoattenuated PfSPZ malaria vaccines induce sterile hepatic immunity.
Mwakingwe-Omari A; Healy SA; Lane J; Cook DM; Kalhori S; Wyatt C; Kolluri A; Marte-Salcedo O; Imeru A; Nason M; Ding LK; Decederfelt H; Duan J; Neal J; Raiten J; Lee G; Hume JCC; Jeon JE; Ikpeama I; Kc N; Chakravarty S; Murshedkar T; Church LWP; Manoj A; Gunasekera A; Anderson C; Murphy SC; March S; Bhatia SN; James ER; Billingsley PF; Sim BKL; Richie TL; Zaidi I; Hoffman SL; Duffy PE
Nature; 2021 Jul; 595(7866):289-294. PubMed ID: 34194041
[TBL] [Abstract][Full Text] [Related]
14. Safety and Differential Antibody and T-Cell Responses to the
Jongo SA; Church LWP; Mtoro AT; Chakravarty S; Ruben AJ; Swanson PA; Kassim KR; Mpina M; Tumbo AM; Milando FA; Qassim M; Juma OA; Bakari BM; Simon B; James ER; Abebe Y; Kc N; Saverino E; Gondwe L; Studer F; Fink M; Cosi G; El-Khorazaty J; Styers D; Seder RA; Schindler T; Billingsley PF; Daubenberger C; Sim BKL; Tanner M; Richie TL; Abdulla S; Hoffman SL
Am J Trop Med Hyg; 2019 Jun; 100(6):1433-1444. PubMed ID: 30994090
[TBL] [Abstract][Full Text] [Related]
15. Heterologous protection against malaria by a simple chemoattenuated PfSPZ vaccine regimen in a randomized trial.
Sulyok Z; Fendel R; Eder B; Lorenz FR; Kc N; Karnahl M; Lalremruata A; Nguyen TT; Held J; Adjadi FAC; Klockenbring T; Flügge J; Woldearegai TG; Lamsfus Calle C; Ibáñez J; Rodi M; Egger-Adam D; Kreidenweiss A; Köhler C; Esen M; Sulyok M; Manoj A; Richie TL; Sim BKL; Hoffman SL; Mordmüller B; Kremsner PG
Nat Commun; 2021 May; 12(1):2518. PubMed ID: 33947856
[TBL] [Abstract][Full Text] [Related]
16. Multidose Priming and Delayed Boosting Improve Plasmodium falciparum Sporozoite Vaccine Efficacy Against Heterologous P. falciparum Controlled Human Malaria Infection.
Lyke KE; Singer A; Berry AA; Reyes S; Chakravarty S; James ER; Billingsley PF; Gunasekera A; Manoj A; Murshedkar T; Laurens MB; Church WP; Garver Baldwin LS; Sedegah M; Banania G; Ganeshan H; Guzman I; Reyes A; Wong M; Belmonte A; Ozemoya A; Belmonte M; Huang J; Villasante E; Sim BKL; Hoffman SL; Richie TL; Epstein JE;
Clin Infect Dis; 2021 Oct; 73(7):e2424-e2435. PubMed ID: 32920641
[TBL] [Abstract][Full Text] [Related]
17. Increase of Dose Associated With Decrease in Protection Against Controlled Human Malaria Infection by PfSPZ Vaccine in Tanzanian Adults.
Jongo SA; Church LWP; Mtoro AT; Schindler T; Chakravarty S; Ruben AJ; Swanson PA; Kassim KR; Mpina M; Tumbo AM; Milando FA; Qassim M; Juma OA; Bakari BM; Simon B; James ER; Abebe Y; Kc N; Saverino E; Fink M; Cosi G; Gondwe L; Studer F; Styers D; Seder RA; Schindler T; Billingsley PF; Daubenberger C; Sim BKL; Tanner M; Richie TL; Abdulla S; Hoffman SL
Clin Infect Dis; 2020 Dec; 71(11):2849-2857. PubMed ID: 31782768
[TBL] [Abstract][Full Text] [Related]
18. Immunization of Malaria-Preexposed Volunteers With PfSPZ Vaccine Elicits Long-Lived IgM Invasion-Inhibitory and Complement-Fixing Antibodies.
Zenklusen I; Jongo S; Abdulla S; Ramadhani K; Lee Sim BK; Cardamone H; Flannery EL; Nguyen T; Fishbaugher M; Steel RWJ; Betz W; Carmago N; Mikolajczak S; Kappe SHI; Hoffman SL; Sack BK; Daubenberger C
J Infect Dis; 2018 Apr; 217(10):1569-1578. PubMed ID: 29438525
[TBL] [Abstract][Full Text] [Related]
19. PfSPZ-CVac efficacy against malaria increases from 0% to 75% when administered in the absence of erythrocyte stage parasitemia: A randomized, placebo-controlled trial with controlled human malaria infection.
Murphy SC; Deye GA; Sim BKL; Galbiati S; Kennedy JK; Cohen KW; Chakravarty S; Kc N; Abebe Y; James ER; Kublin JG; Hoffman SL; Richie TL; Jackson LA
PLoS Pathog; 2021 May; 17(5):e1009594. PubMed ID: 34048504
[TBL] [Abstract][Full Text] [Related]
20. A First for Human Vaccinology: GMP Compliant Radiation Attenuation of
James ER; Matheny S; Overby J; Sim BKL; Eappen AG; Li T; Li ML; Richie TL; Chakravarty S; Gunasekera A; Murshedkar T; Billingsley PF; Hoffman SL
Front Immunol; 2022; 13():851028. PubMed ID: 35242146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
